Cargando…
Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
SIMPLE SUMMARY: Targeting receptor activator of nuclear factor-κB ligand (RANKL) with the monoclonal antibody Denosumab decreases osteoclast-mediated bone resorption and is approved for the treatment of postmenopausal osteoporosis. Since RANKL is also implicated in mammary gland homeostasis and brea...
Autores principales: | Kolokotroni, Anthi, Gkikopoulou, Evi, Rinotas, Vagelis, Ntari, Lydia, Zareifi, Danae, Rouchota, Maritina, Sarpaki, Sophia, Lymperopoulos, Ilias, Alexopoulos, Leonidas G., Loudos, George, Denis, Maria C., Karagianni, Niki, Douni, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417415/ https://www.ncbi.nlm.nih.gov/pubmed/37568820 http://dx.doi.org/10.3390/cancers15154006 |
Ejemplares similares
-
New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
por: Papadaki, Maria, et al.
Publicado: (2019) -
Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis
por: Christodoulou-Vafeiadou, Eleni, et al.
Publicado: (2020) -
Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks
por: Fysikopoulos, Eleftherios, et al.
Publicado: (2021) -
In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
por: Melagraki, Georgia, et al.
Publicado: (2018) -
Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
por: Rinotas, Vagelis, et al.
Publicado: (2023)